DE60330758D1 - Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen - Google Patents
Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclenInfo
- Publication number
- DE60330758D1 DE60330758D1 DE60330758T DE60330758T DE60330758D1 DE 60330758 D1 DE60330758 D1 DE 60330758D1 DE 60330758 T DE60330758 T DE 60330758T DE 60330758 T DE60330758 T DE 60330758T DE 60330758 D1 DE60330758 D1 DE 60330758D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted amino
- amino alkyl
- certain pharmaceutically
- pharmaceutically valuable
- alkyl heterocycles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36841502P | 2002-03-27 | 2002-03-27 | |
PCT/US2003/009039 WO2003082192A2 (en) | 2002-03-27 | 2003-03-26 | Certain pharmaceutically useful substituted aminoalkyl heterocycles |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60330758D1 true DE60330758D1 (de) | 2010-02-11 |
Family
ID=28675483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60330758T Expired - Lifetime DE60330758D1 (de) | 2002-03-27 | 2003-03-26 | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen |
Country Status (8)
Country | Link |
---|---|
US (1) | US7323494B2 (de) |
EP (1) | EP1490047B1 (de) |
JP (1) | JP2005521705A (de) |
AT (1) | ATE453389T1 (de) |
AU (1) | AU2003223340A1 (de) |
DE (1) | DE60330758D1 (de) |
ES (1) | ES2337037T3 (de) |
WO (1) | WO2003082192A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002024632A2 (en) * | 2000-09-18 | 2002-03-28 | Glaxo Group Limited | Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
US7247748B2 (en) | 2002-03-27 | 2007-07-24 | Smithkline Corporation | Amide compounds and methods of using the same |
WO2003082205A2 (en) | 2002-03-27 | 2003-10-09 | Smithkline Beecham Corporation | Compounds and methods |
EP1511483A4 (de) * | 2002-03-27 | 2009-03-18 | Smithkline Beecham Corp | Verfahren zur behandlung mit lxr-modulatoren |
WO2003082802A1 (en) | 2002-03-27 | 2003-10-09 | Smithkline Beecham Corporation | Acid and ester compounds and methods of using the same |
CA2504878A1 (en) * | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorption inhibitors for the treatment of demyelination |
FR2869904B1 (fr) | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | Modulateurs des recepteurs lxr |
IL166149A0 (en) * | 2005-01-05 | 2006-01-15 | Hadasit Med Res Service | Use of ezetimibe and amiodarone in protection against beta-amyloid neurotoxicity |
JP5159633B2 (ja) | 2006-11-30 | 2013-03-06 | 興和株式会社 | 置換カルビノール化合物 |
WO2009107387A1 (ja) | 2008-02-29 | 2009-09-03 | 興和株式会社 | 2-オキソクロメン誘導体 |
EP2264029A4 (de) | 2008-03-31 | 2011-08-24 | Kowa Co | 1,3-dihydroisobenzofuran-derivat |
EP2272843A4 (de) | 2008-04-30 | 2011-07-20 | Kowa Co | Chinolinverbindung |
JP5541803B2 (ja) | 2008-05-29 | 2014-07-09 | 興和株式会社 | 環状リンカーを有する置換カルビノール化合物 |
AU2010243044C1 (en) | 2009-04-29 | 2016-08-25 | Kowa Company, Ltd. | Carbinol compound having heterocyclic linker |
WO2012033353A2 (ko) | 2010-09-07 | 2012-03-15 | 서울대학교 산학협력단 | 세스터터핀 화합물 및 이들 물질의 용도 |
AU2018226879B2 (en) | 2017-03-03 | 2023-09-14 | Inspirna, Inc. | Formulations with improved stability |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989003819A1 (en) | 1987-10-20 | 1989-05-05 | Otsuka Pharmaceutical Co., Ltd. | Phenylcarboxylic acid derivatives |
US20030153541A1 (en) | 1997-10-31 | 2003-08-14 | Robert Dudley | Novel anticholesterol compositions and method for using same |
US6316503B1 (en) | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
WO2001060818A1 (en) | 2000-02-14 | 2001-08-23 | Tularik Inc. | Lxr modulators |
WO2002024632A2 (en) | 2000-09-18 | 2002-03-28 | Glaxo Group Limited | Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
US20030229062A1 (en) | 2001-12-07 | 2003-12-11 | The Regents Of The University Of California | Treatments for age-related macular degeneration (AMD) |
US7470659B2 (en) | 2001-12-07 | 2008-12-30 | The Regents Of The University Of California | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
JP2005511713A (ja) | 2001-12-07 | 2005-04-28 | ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア | 加齢性黄斑変性についての処置 |
EP1511483A4 (de) * | 2002-03-27 | 2009-03-18 | Smithkline Beecham Corp | Verfahren zur behandlung mit lxr-modulatoren |
WO2003082802A1 (en) | 2002-03-27 | 2003-10-09 | Smithkline Beecham Corporation | Acid and ester compounds and methods of using the same |
WO2003082205A2 (en) | 2002-03-27 | 2003-10-09 | Smithkline Beecham Corporation | Compounds and methods |
US7247748B2 (en) | 2002-03-27 | 2007-07-24 | Smithkline Corporation | Amide compounds and methods of using the same |
AU2003301216A1 (en) | 2002-12-23 | 2004-07-22 | Irm Llc | Novel use of liver x receptor agonists |
GB0230177D0 (en) | 2002-12-24 | 2003-02-05 | Karobio Ab | LXR beta crystal |
WO2004110375A2 (en) | 2003-06-06 | 2004-12-23 | Merck & Co., Inc. | Combination therapy for the treatment of diabetes |
WO2004110368A2 (en) | 2003-06-06 | 2004-12-23 | Merck & Co., Inc. | Combination therapy for the treatment of hypertension |
US20060189693A1 (en) | 2003-07-22 | 2006-08-24 | Barone Frank C | Methods of treatment with lxr agonists |
EP1653938A2 (de) | 2003-07-28 | 2006-05-10 | Glaxo Group Limited | Verfahren zur behandlung von chronisch entzündlichen darmerkrankungen mit lxr-agonisten |
WO2005055998A1 (en) | 2003-12-04 | 2005-06-23 | Smithkline Beecham Corporation | Methods of treatment with lxr agonists |
BRPI0417543A (pt) | 2003-12-12 | 2007-03-27 | Wyeth Corp | quinolinas úteis no tratamento de doença cardiovascular |
JP2008503547A (ja) | 2004-06-24 | 2008-02-07 | ガラパゴス・ナムローゼ・フェンノートシャップ | 骨ホメオスタシスを促進させる方法及び組成物 |
WO2006004030A1 (ja) | 2004-07-02 | 2006-01-12 | Sankyo Company, Limited | 組織因子産生抑制剤 |
-
2003
- 2003-03-26 WO PCT/US2003/009039 patent/WO2003082192A2/en active Application Filing
- 2003-03-26 JP JP2003579735A patent/JP2005521705A/ja active Pending
- 2003-03-26 AT AT03719457T patent/ATE453389T1/de not_active IP Right Cessation
- 2003-03-26 ES ES03719457T patent/ES2337037T3/es not_active Expired - Lifetime
- 2003-03-26 DE DE60330758T patent/DE60330758D1/de not_active Expired - Lifetime
- 2003-03-26 EP EP03719457A patent/EP1490047B1/de not_active Expired - Lifetime
- 2003-03-26 AU AU2003223340A patent/AU2003223340A1/en not_active Abandoned
- 2003-03-26 US US10/508,822 patent/US7323494B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20050165045A1 (en) | 2005-07-28 |
JP2005521705A (ja) | 2005-07-21 |
US7323494B2 (en) | 2008-01-29 |
EP1490047A2 (de) | 2004-12-29 |
AU2003223340A1 (en) | 2003-10-13 |
AU2003223340A8 (en) | 2003-10-13 |
WO2003082192A2 (en) | 2003-10-09 |
EP1490047A4 (de) | 2006-01-04 |
ATE453389T1 (de) | 2010-01-15 |
ES2337037T3 (es) | 2010-04-20 |
EP1490047B1 (de) | 2009-12-30 |
WO2003082192A3 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60107449D1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
WO2003082205A3 (en) | Compounds and methods | |
NL300877I2 (nl) | obeticholzuur | |
DE60330758D1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
DE69919397D1 (de) | Thrombin-inhibitoren | |
ATE297203T1 (de) | Antithrombotische mitteln | |
EA200500814A1 (ru) | Производные пирролопиримидина | |
TW200510441A (en) | Novel compounds | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
DE60130771D1 (de) | Substituierte heterocyclische amide | |
MXPA05011411A (es) | 1,4-diazepinas sustituidas y usos de las mismas. | |
PA8573501A1 (es) | Derivados de benzoxazina y su empleo | |
WO2005003087A3 (en) | Oxazole derivatives as antibacterial agents | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
ATE308540T1 (de) | Antithrombosemittel | |
DK1209151T3 (da) | 4-substituerede piperidinderivativer | |
WO2003093247A3 (en) | Antibacterial agents | |
DE69329184D1 (de) | Alkylsubstituierte heterocyclische Verbindungen | |
TW200508211A (en) | 2-naphthylimino-1,3-thiazine derivatives | |
WO2003103599A3 (en) | CASPASE-1 INHIBITORS AND METHODS OF USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: GLAXOSMITHKLINE LLC, PHILADELPHIA, PA., US |
|
8364 | No opposition during term of opposition |